Evosep at US HUPO 2026
We are thrilled to once again participate at the annual Human Proteomics Conference, which will take place in St. Louis, Missouri on February 21 – 25, 2026. Please visit us at our booth, where will be happy to introduce you to our technology and how we can contribute with fully automated and standardized workflows. You are also welcome to join our Evosep Breakfast Seminar – register and secure your seat now.
Monday, February 23rd, 2026: 07:15AM – 08:15AM – Room: Grand GH
US HUPO 2026 breakfast seminar
Standardizing and scaling automated workflows for cutting edge proteomics
Join us for breakfast and get the newest data of proteomics workflows, scientific discussions, and new discoveries from Evosep. Learn more about the full programme at US HUPO 2026
Monday, February 23rd, 2026: 07:15AM – 08:15AM – Room: Grand GH
US HUPO 2026 breakfast seminar
Standardizing and scaling automated workflows for cutting edge proteomics
Join us for breakfast and get the newest data of proteomics workflows, scientific discussions, and new discoveries from Evosep. Learn more about the full programme at US HUPO 2026
Toward robust and reproducible single cell proteomics?
Talk by Ben Orsburn, Assistant Professor at the University of Pittsburgh’s Organ Pathobiology and Therapeutics Institute
Single cell proteomics has captured the imagination of a range of biologists and clinicians who are pushing, or have found, the limits of other single cell technologies. Mass spectrometrists are now under pressure to deliver routine and reproducible data from hundreds or thousands of isolated single cells. In this talk I will describe both our label free and labeled single cell workflows which are enabled in part by large scale sample cleanup and standardized methods using EvoSep technologies. I’ll describe workflows where label free methods are used when proteomic depth is paramount and multiple examples of exceeding 5,000 proteins per human cell. When leveraging multiplexing, we exchange proteomic depth for the ability to analyze 700 cells/day after blank and control wells through on-tip pooling and cleanup of samples.
Using protein enrichment and high-throughput proteomics to identify circulating biomarkers for amyloid conversion and early cognitive decline in matched plasma and CSF samples
Talk by Jan Muntel, PhD, Vice President of Scientific Operations, North America, at Biognosys Group
Reliable biomarkers for Alzheimer’s disease (AD) are urgently needed to identify individuals at the very earliest stages of disease, ideally before cognitive changes appear and even prior to amyloid conversion. To address this, we applied enrichment strategies for plasma and CSF combined with robust and reproducible analysis on an Evosep combined with timsTOF mass spectrometer which resulted in more than 6,500 proteins per plasma sample and more than 3’500 proteins in CSF samples. The resulting proteomic profiles revealed molecular alterations in both plasma and CSF that preceded amyloid conversion and cognitive decline.
Featured Poster Presentations
P10.01 – Unlocking next-generation insights in LC-MS based proteomics with a scalable and cost-efficient workflow strategy subjected to more than 1,000 samples
When and where: Monday, February 23, 4:30 – 6:30 PM.
Lightning talk session 01
Title to be announced
When and where: Monday, February 23, 4:30 – 6:30 PM in Grand DE
Register for Evosep activities at US HUPO 2026
We cannot wait to be back and would love for you to join us!
